Numares Health AG, based in Regensburg, Germany, is an innovative diagnostics company that applies machine learning to metabolomics and other biomarker data to develop advanced tests for high-throughput use in clinical diagnostics. The AXINON® System employs advanced nuclear magnetic resonance (NMR) spectroscopy to evaluate metabolic constellations. Magnetic Group Signaling (MGS®) is a proprietary technology that enables NMR for highly standardized and rapid throughput testing. Metabolic tests stand as an important pillar in precision medicine to address unmet needs in cardiovascular, kidney, liver and neurological diseases. Numares AG Am BioPark 9 93053 Regensburg Phone: +49 941 280 949-00 Fax: +49 941 280 949-50 E-Mail: info(at)numares.com www.numares.com Executive Board: Winton Gibbons (chairman), Dr. Claus Botzler, Florian Voß Supervisory Board: Uwe Steinbacher (chairman), Volker Pfahlert, Kathy L. Bates, Dr. Rainer Kutzner, Dr. Gerhard Ries, Dr. Gregory F. Heath Registered office: Regensburg Location of court: Regensburg HRB 14269